| Zena Kay Homan, MD | |
|
3000 32nd Ave S, Fargo, ND 58103-6132 | |
| (701) 364-8000 | |
| (701) 364-8078 |
| Full Name | Zena Kay Homan |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 3000 32nd Ave S, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003006651 | NPI | - | NPPES |
| 16201 | Medicaid | ND |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovis Health Llc | 9931298155 | 473 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
TCG today announced that Acousticon Inc., one of its portfolio companies, recently received FDA clearance for its ACAM-5 product, allowing the company to begin US commercialization activities for the first time.
In the first published trial of its kind, a multi-center clinical study has shown that drug-eluting stents outperform the current "gold standard" radiation treatment in managing coronary restenosis and in preventing further clogging of coronary arteries.
The Virginia case, brought by state Attorney General Ken Cuccinelli, was considered one of the highest profile health law challenges to the health law. In its opinion, issued today, the court ruled that the state does not have standing to challenge the law's individual mandate because it lacks "a personal stake." The appellate court also concluded that Liberty University's challenge should be dismissed.
› Verified 2 days ago
| Entity Name | Innovis Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215125463 PECOS PAC ID: 9931298155 Enrollment ID: O20071211000158 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
TCG today announced that Acousticon Inc., one of its portfolio companies, recently received FDA clearance for its ACAM-5 product, allowing the company to begin US commercialization activities for the first time.
In the first published trial of its kind, a multi-center clinical study has shown that drug-eluting stents outperform the current "gold standard" radiation treatment in managing coronary restenosis and in preventing further clogging of coronary arteries.
The Virginia case, brought by state Attorney General Ken Cuccinelli, was considered one of the highest profile health law challenges to the health law. In its opinion, issued today, the court ruled that the state does not have standing to challenge the law's individual mandate because it lacks "a personal stake." The appellate court also concluded that Liberty University's challenge should be dismissed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zena Kay Homan, MD Po Box 6001, Fargo, ND 58108-6001 Ph: (701) 364-8000 | Zena Kay Homan, MD 3000 32nd Ave S, Fargo, ND 58103-6132 Ph: (701) 364-8000 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
TCG today announced that Acousticon Inc., one of its portfolio companies, recently received FDA clearance for its ACAM-5 product, allowing the company to begin US commercialization activities for the first time.
In the first published trial of its kind, a multi-center clinical study has shown that drug-eluting stents outperform the current "gold standard" radiation treatment in managing coronary restenosis and in preventing further clogging of coronary arteries.
The Virginia case, brought by state Attorney General Ken Cuccinelli, was considered one of the highest profile health law challenges to the health law. In its opinion, issued today, the court ruled that the state does not have standing to challenge the law's individual mandate because it lacks "a personal stake." The appellate court also concluded that Liberty University's challenge should be dismissed.
› Verified 2 days ago
Jeffrey Allen Rondeau, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2400 32nd Ave S, Fargo, ND 58103 Phone: 701-234-8880 Fax: 701-234-8995 | |
Christine Keup, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2241 | |
Dr. John Michael Balintona, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Margaret Traynor Mickelson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2241 Fax: 701-234-4877 | |
Dr. Denise M Schumacher, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4450 31st Ave S Ste 102, Fargo, ND 58104 Phone: 012-802-0337 Fax: 701-232-5578 | |
Walter C Bro, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 Fax: 701-234-4877 |